Procter & Gamble to reduce focus on pharmaceuticals
This article was originally published in Scrip
Executive Summary
Procter & Gamble's decision to focus on consumer healthcare and to de-emphasise its focus on pharmaceuticals casts a shadow over its four key pharmaceutical brands Actonel (risedronate sodium), Asacol (mesalazine), Intrinsa (testosterone) and Enablex (darifenacin).